InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,564.00
(
-2.20%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.24%
)
Bitcoin
63,631.17
(
0.19%
)
Post# of 41945
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mick Dodge

Send PM Follow Ignore
Followers 580
Posts 61808
Boards Moderated 3
Alias Born 03/02/2010

Mick Dodge

Re: None

Tuesday, 10/21/2014 9:21:31 AM

Tuesday, October 21, 2014 9:21:31 AM

Post# of 41945
Compensated Awareness Post View Disclaimer
$IMMB With the establishment of an African operation, Immunotech hopes to fulfill the Company's vision of bringing a therapy based on the patented Inactivated Pepsin Fraction (IPF) protein developed by Immunotech for infectious diseases such as HIV/AIDS, Hepatitis C and a new potential initiative, the Ebola virus. In parts of Africa, approved experimental treatments are permitted, and with the Ebola outbreak, Immunotech expects that it can market its treatment for infectious diseases through the Company’s new agreement with Uldic.

http://finance.yahoo.com/news/immunotech-laboratories-inc-enters-agreement-120000239.html

IF YOU LIKE THE CHARTS HIT ME UP WITH A PERSON MARK
http://investorshub.advfn.com/boards/profilea.aspx?user=192141

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up